Cigna pioneers solution for life-changing therapies

Cigna Health Services Business announces a significant new way we’re advancing healthcare. We are proud to introduce Embarc Benefit ProtectionSM, the industry’s first solution to begin to address the high cost of certain potentially curative gene therapy medicines.

Embarc Benefit Protection fills a critical, unmet need that offers a pathway for payers to provide coverage for some of these potentially life-altering cures under their plans. They will now be within reach for individuals covered by a plan with an Embarc solution. Focused on making these breakthrough drugs more affordable for payers and ensuring access to coverage for customers, this solution draws upon the collective capabilities of eviCore, Accredo, Express Scripts and Cigna, demonstrating the power of our combined organization. We anticipate Embarc Benefit Protection will be available in 2020.

Learn more here.

Legal Disclaimer | Privacy | Product Disclosures | Cigna Company Names

Health benefit plans vary, but in general to be eligible for coverage a drug must be approved by the Food and Drug Administration (FDA), prescribed by a health care professional, purchased from a licensed pharmacy and medically necessary. Some plans require you to use an in-network pharmacy for prescriptions to be covered. Coverage is subject to any plan deductible, copayment and/or coinsurance requirements. Product availability may vary by location and plan type and is subject to change. All group health insurance policies and health benefit plans contain exclusions and limitations. For costs and details of coverage, contact a Cigna representative. Group medical and pharmacy plans are insured and/or administered by Cigna Health and Life Insurance Company or its affiliates. Policy forms: OK - HP-APP-1 et al., OR - HP-POL38 02-13, TN - HP-POL43/HC-CER1V1 et al. All pictures are used for illustrative purposes only. This website is not intended for residents of New Mexico.

© 2020 Cigna. All rights reserved